Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (91-100 of 250) with videos related to

Pageof 25
Sort By:
Journal of Breast Cancer|August 18, 2011
Efficacy of fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer: a preliminary reportChanghoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, et al.
Frontiers in Oncology|August 9, 2021
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder AdenocarcinomaYou-Na Sung, Sung Joo Kim, Sun-Young Jun, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Cancer Research and Treatment|May 10, 2024
Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular CarcinomaSe Jin Choi, Sung Won Chung, Jonggi Choi, et al.
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
Radiology|July 15, 2020
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk ScoreDong Wook Kim, Seung Soo Lee, Seon-Ok Kim, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2010
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailabilityKyu-pyo Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinibChanghoon Yoo, Min-Hee Ryu, Byung Woog Kang, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2013
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort studyChanghoon Yoo, Mi Ra Yun, Jin-Hee Ahn, et al.
Annals of Surgical Oncology|January 22, 2015
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrenceChanghoon Yoo, Min-Hee Ryu, Young Soo Park, et al.
Pageof 25

Showing results (91-100 of 250) with videos related to

Sort By:
Pageof 25
Journal of Breast Cancer|August 18, 2011
Efficacy of fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer: a preliminary reportChanghoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, et al.
Frontiers in Oncology|August 9, 2021
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder AdenocarcinomaYou-Na Sung, Sung Joo Kim, Sun-Young Jun, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Cancer Research and Treatment|May 10, 2024
Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular CarcinomaSe Jin Choi, Sung Won Chung, Jonggi Choi, et al.
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
Radiology|July 15, 2020
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk ScoreDong Wook Kim, Seung Soo Lee, Seon-Ok Kim, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2010
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailabilityKyu-pyo Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinibChanghoon Yoo, Min-Hee Ryu, Byung Woog Kang, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2013
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort studyChanghoon Yoo, Mi Ra Yun, Jin-Hee Ahn, et al.
Annals of Surgical Oncology|January 22, 2015
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrenceChanghoon Yoo, Min-Hee Ryu, Young Soo Park, et al.
Pageof 25